First-in-human trial evaluates dosing of metallo-beta-lactamase inhibitor
Source/Disclosures Published by: sources: Gillespie G, et al. First-in-human studies of Mk-3402, a pan metallo-beta-lactamase inhibitor to combat antimicrobial resistance.
Read More